Modelled DT Structure
Method: multi-sequence alignment based machine learning
Detail: Structure Info
General Information of DT | |||||
---|---|---|---|---|---|
DT ID | DTD0187 | ||||
Gene Name | SLC25A26 | ||||
Protein Name | S-adenosylmethionine mitochondrial carrier protein | ||||
Gene ID | |||||
UniProt ID | |||||
TCDB ID | |||||
3D Structure |
Modelled DT Structure Method: multi-sequence alignment based machine learning Detail: Structure Info |
||||
Synonyms | COXPD28; Mitochondrial S-adenosylmethionine transporter; SAMC; SLC25A26; Solute carrier family 25 member 26 | ||||
DT Family | Mitochondrial Carrier (MC) Family ; | ||||
Tissue Specificity | Widely expressed. Highly expressed in testis,with moderate expression in brain, heart, kidney, lung, skeletalmuscle, pancreas, small intestine and liver, and low expression inspleen. | ||||
Function | This transporter specifically mediates the transport of S-adenosylmethionine (SAM) into the mitochondria and shuttle metabolites, nucleotides, and cofactors through the mitochondrial inner membrane. | ||||
Endogenous Substrate(s) | S-adenosylmethionine | ||||
Variability Data of This Drug Transporter (DT) | |||||
Regulatory Variability Data of This DT (VARIDT 3.0) |
|||||
(β) Post-translational Modification of This DT |
|||||
(γ) Transcriptional Regulation of This DT |
|||||
(δ) Epigenetic Regulation of This DT |
|||||
General Variability Data of This DT (VARIDT 1.0) |
|||||
(β) Disease-specific Protein Abundances of This DT |
|||||
(γ) Species- and Tissue-specific DT Abundances |
|||||
Molecular Transporting Profile of This DT | |||||
Full List of Drug(s) Transported by This DT |
|||||
Clinical Trial Drug |
Click to Show/Hide the Full List of Drug: 1 Drugs in Total | ||||
Drug Name | Highest Status | Detail | Indication | ICD 11 | Ref |
S-adenosylmethionine
|
Phase 3 | Drug Info | Alcoholic liver disease | DB94 | [1] |
References | |||||
1 | FOXD3 acts as a repressor of the mitochondrial S-adenosylmethionine carrier (SLC25A26) gene expression in cancer cells. Biochimie. 2018 Nov;154:25-34. | ||||
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.